Literature DB >> 22298454

Eucommiae cortex inhibits TNF-α and IL-6 through the suppression of caspase-1 in lipopolysaccharide-stimulated mouse peritoneal macrophages.

Min-Cheol Kim1, Dae-Seung Kim, Su-Jin Kim, Jinbong Park, Hye-Lin Kim, Seon-Young Kim, Kwang Seok Ahn, Hyeung-Jin Jang, Seok-Geun Lee, Kang-Min Lee, Seung-Heon Hong, Jae-Young Um.   

Abstract

Eucommiae cortex (EC) is used in various traditional Korean medicines in the form of tonics, analgesics, and sedatives. However, the underlying mechanism of its anti-inflammatory effect remains unclear. This study attempts to determine the effects of EC on lipopolysaccharide (LPS)-induced inflammatory responses in mouse peritoneal macrophages. The findings of the study show that EC inhibits the LPS-induced production of tumor necrosis factor-alpha and interleukin-6. Exposure to EC also reduces an inflammation-induced increase in the levels of cyclooxigenase-2 and the production of prostaglandin E(2) and nitric oxide in mouse peritoneal macrophages. Furthermore, EC suppresses the activation of nuclear factor-kappa B and caspase-1. These results provide novel insights into the pharmacological action of EC and indicate that EC has a potential in the treatment of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22298454     DOI: 10.1142/S0192415X12500115

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  5 in total

1.  A UPLC-MS Method for Simultaneous Determination of Geniposidic Acid, Two Lignans and Phenolics in Rat Plasma and its Application to Pharmacokinetic Studies of Eucommia ulmoides Extract in Rats.

Authors:  Yongjun Li; Zipeng Gong; Xu Cao; Yonglin Wang; Aimin Wang; Lin Zheng; Yong Huang; Yanyu Lan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

2.  Efficacy and safety of Cortex Eucommiae (Eucommia ulmoides Oliver) extract in subjects with mild osteoarthritis: Study protocol for a 12-week, multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  Hyeon Yeong Ahn; Jae-Heung Cho; Dongwoo Nam; Eun-Jung Kim; In-Hyuk Ha
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

3.  The Anti-Inflammatory Activity of Eucommia ulmoides Oliv. Bark. Involves NF-κB Suppression and Nrf2-Dependent HO-1 Induction in BV-2 Microglial Cells.

Authors:  Seung-Hwan Kwon; Shi-Xun Ma; Ji-Young Hwang; Yong-Hyun Ko; Ji-Yeon Seo; Bo-Ram Lee; Seok-Yong Lee; Choon-Gon Jang
Journal:  Biomol Ther (Seoul)       Date:  2016-05-01       Impact factor: 4.634

Review 4.  Health-Promoting Properties of Eucommia ulmoides: A Review.

Authors:  Tarique Hussain; Bi'e Tan; Gang Liu; Oso Abimbola Oladele; Najma Rahu; M C Tossou; Yulong Yin
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-02       Impact factor: 2.629

Review 5.  Traditional application and modern pharmacological research of Eucommia ulmoides Oliv.

Authors:  Lichuang Huang; Qiang Lyu; Wanying Zheng; Qiao Yang; Gang Cao
Journal:  Chin Med       Date:  2021-08-06       Impact factor: 5.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.